navnath s gavande
Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University
Detroit, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University
Detroit, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Associate Editor
Pharmacology of Anti-Cancer Drugs
Sapienza University of Rome
Rome, Italy
Associate Editor
Molecular and Cellular Oncology
University of Turin
Turin, Italy
Associate Editor
Pharmacology of Anti-Cancer Drugs
University of Salerno
Fisciano, Italy
Associate Editor
Pharmacology of Anti-Cancer Drugs
Kore University of Enna
Enna, Italy
Associate Editor
Breast Cancer
Amsterdam University Medical Center
Amsterdam, Netherlands
Associate Editor
Breast Cancer
University of Calabria
Cosenza, Italy
Associate Editor
Breast Cancer
Department of Neurosurgery, University Hospital rechts der Isar, Technical University of Munich
Munich, Germany
Associate Editor
Neuro-Oncology and Neurosurgical Oncology
University of Trieste
Trieste, Italy
Associate Editor
Breast Cancer
Department of Hematology and Oncology, Health Agency of Cosenza
Cosenza, Italy
Associate Editor
Hematologic Malignancies
Unit of Clinical Hematology, Cosenza Hospital
Cosenza, Italy
Associate Editor
Hematologic Malignancies
University of Florence
Florence, Italy
Associate Editor
Cancer Immunity and Immunotherapy
University of Texas at Austin School of Nursing
Austin, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Roswell Park Comprehensive Cancer Center, University at Buffalo
Buffalo, United States
Associate Editor
Genitourinary Oncology
McGill University
Montreal, Canada
Associate Editor
Pharmacology of Anti-Cancer Drugs